Platelet activation in patients with atherosclerotic renal artery stenosis undergoing stent revascularization Article (Faculty180)

cited authors

  • Haller, Steven; Adlakha, Satjit; Reed, Grant; Brewster, Pamela; Kennedy, David; Burket, Mark W; Colyer, William; Yu, Haifeng; Zhang, Dong; Shapiro, Joseph I; Cooper, Christopher J

description

  • Soluble CD40 ligand (sCD40L) is a marker of platelet activation; whether platelet activation occurs in the setting of renal artery stenosis and stenting is unknown. Additionally, the effect of embolic protection devices and glycoprotein IIb/IIIa inhibitors on platelet activation during renal artery intervention is unknown.

publication date

  • 2011

start page

  • 2185

end page

  • 91

volume

  • 6